There are 2789 resources available
Q&A and live discussion
Presenter: Solange Peters
Session: ESMO Virtual Plenary Debate – Discussion session II: Lung cancer
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Jordi Rodon
Session: Targeting molecular residual disease in solid tumours will increase cure rates?
Resources:
Slides
Webcast
Yes
Presenter: Lillian L Siu
Session: Targeting molecular residual disease in solid tumours will increase cure rates?
Resources:
Slides
Webcast
No
Presenter: Anastasios Stathis
Session: Targeting molecular residual disease in solid tumours will increase cure rates?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Jordi Rodon
Session: Targeting molecular residual disease in solid tumours will increase cure rates?
Resources:
Slides
Webcast
Q&A
Presenter: Jordi Rodon
Session: Targeting molecular residual disease in solid tumours will increase cure rates?
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Krishnansu S Tewari
Session: ESMO Virtual Plenary Debate – Discussion session III: Gynaecological cancer
Resources:
Slides
Webcast
862MO - Gene expression profile differentiates short-term and long-term survivors with immunotherapy in patients with recurrent/metastatic head and neck cancer
Presenter: Loris De Cecco
Session: Mini oral session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
1670MO - Validation of a new risk-assessment model for prediction of venous thromboembolism in cancer outpatients: The ONKOTEV score
Presenter: Chiara Alessandra Cella
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1443MO - Differences in hematologists’ and palliative care physicians’ recommended indications and opinions on transfusion therapy for patients with hematological malignancy post-anticancer therapy
Presenter: Yukako Hattori
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast